EIKON THERAPEUTICS, INC. (EIKN) Market Cap
- 2026-09-03: Market Cap $591.48M.
- 2026-08-03: Market Cap $495.61M.
- 2026-06-30: Market Cap $706.64M.
- 2026-05-01: Market Cap $524.06M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2026-03-31 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $591.48M |
| 2026-08-03 | $495.61M |
| 2026-06-30 | $706.64M |
| 2026-05-01 | $524.06M |
| 2026-03-31 | $572.79M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |